Skip to content

Clinical trials

Bone Diseases, Metabolic trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases, Metabolic Country / region: Australia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20061
20092
20101
20122
20151
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
AO Innovation Translation Center1
Cephalon1
Novartis1
Novartis Pharmaceuticals1
Solarea Bio, Inc1
St Vincent's Hospital, Sydney1
University of Melbourne1
Warner Chilcott1
Zimmer Biomet1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases, Metabolic12
Osteoporosis6
Bone Diseases2
Musculoskeletal Diseases2
Osteoporosis, Postmenopausal2
Ankylosis1
Breast Neoplasms1
Cataract1
HIV Infections1
Joint Instability1

Trials

Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.